NEW YORK, Nov. 08, 2017 -- TPP Healthcare, a strategic advisory firm specializing in cross-border transactions between Western and Chinese healthcare companies, announces its launch of www.tppheatlhcare.com – a direct market access strategy site.
On the site, current and prospective clients will find useful information about the global healthcare industry, TPP’s services and recent company production numbers. Additionally, viewers will gain valuable insight on TPP’s network and ability to execute cross-border transactions involving pharmaceuticals/therapeutics, medical devices and diagnostics.
Amongst the new features, the site contains integrated social media buttons to foster two-way communication with clients and updated content with helpful information, articles, blogs, newsletters, company announcements and client successes.
“The Chinese healthcare market and how to access its reach and capital can quickly become complicated and muddled. The goal with the launch of www.tpphealthcare.com is to act as a step ahead towards greater transparency through dissemination of information to the investor and innovative communities,” states Tony Chu, co-founder and managing partner at TPP Healthcare. “We are excited to share our insight and reach publicly and encourage interested parties to take advantage of the site.”
Interesting Links:
- #TPPINIGHTS BLOG: The latest news, thoughts and trends from within TPP and across the healthcare industry.
- INNOVATOR SERVICES: A dynamic snapshot of how TPP Healthcare can help innovative companies develop long-term, global relationships while protecting them from potential pitfalls.
- INVESTOR SERVICES: Gives followers an idea on how TPP has access to innovation for Chinese investors and companies – gaining tangible and profitable results, on a long-term basis.
- WHO WE ARE: A glimpse into what it is exactly that TPP Healthcare does, who we work with and what we can offer.
To learn more about TPP’s cross-border healthcare innovation and expansion capabilities, please contact Derrick Li, Partner of TPP Healthcare ([email protected]).
About TPP Healthcare
The Pharma Partners (TPP) Healthcare is a global advisory firm that functions to capture the macroeconomic shift of China’s market interest in healthcare innovation. Specializing in cross-border deal flow, TPP Healthcare is comprised of well-connected industry veterans from all over the world – and the largest network in China’s healthcare industry. By serving as a bridge between healthcare companies and investors from China and groundbreaking and innovative products and technologies from North America and Europe, TPP has become the market expert with a top-notch network to execute and support cross-border transactions involving pharmaceuticals/ therapeutics, medical devices and diagnostics.
TPP HEALTHCARE MEDIA CONTACT:
Trisha Salerno
Event Director – TPP Healthcare
750 Third Avenue, 9th Floor
New York, NY 10017
Mobile: (516) 385-0315
E-Mail: [email protected]


Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
GE Aerospace Expands Singapore Engine Repair Hub with Automation and AI to Tackle Aviation Bottlenecks
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
How Marco Pharma International Preserves German Homeopathic Traditions in America
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms 



